Garcia-Retortillo Montserrat, Forns Xavier, Feliu Anna, Moitinho Eduardo, Costa Josep, Navasa Miquel, Rimola Antoni, Rodes Juan
Liver Unit, Institut de Malalties Digestives, Hospital Clinic, University of Barcelona, Villaroel 170, Barcelona 08036, Catalonia, Spain.
Hepatology. 2002 Mar;35(3):680-7. doi: 10.1053/jhep.2002.31773.
The study of hepatitis C virus (HCV) kinetics after liver transplantation (LT) might be important to design strategies to prevent HCV infection of the graft. We analyzed HCV kinetics during and immediately after LT in 20 consecutive patients undergoing LT for HCV-related cirrhosis. HCV RNA was quantified in blood samples obtained at regular intervals before, during, and after transplantation. HCV-RNA concentrations decreased in 18 of 20 patients during the anhepatic phase (mean decay slope -0.92, mean HCV elimination half-life 2.2 hours). We found a significant correlation between the HCV viral load decay and the blood loss during the anhepatic phase, indicating that the observed HCV clearance rates are maximum estimates. In fact, in 1 patient with an unusually long anhepatic phase of 20 hours and with minimum blood loss, the HCV elimination half-life was 10.3 hours. Eight to 24 hours after graft reperfusion a sharp decrease in HCV viral load occurred in 19 patients (mean decay slope -0.34, mean HCV elimination half-life 3.44 hours). HCV RNA became undetectable in only 1 patient. During the following days, HCV-RNA concentrations increased rapidly in 10 patients (mean HCV doubling time 13.8 hours), remained at similar levels in 4, and continued to decrease in 6. The only variable associated with a second-phase viral load decay was the absence of corticosteroids as part of the immunosuppressive regimen. In conclusion, a sharp decrease in HCV viral load occurs during the anhepatic phase and immediately after graft reperfusion, most likely owing to a lack of virion production and hepatic viral clearance. HCV infection of the graft, however, is an extremely dynamic process and viral replication begins a few hours after LT.
研究肝移植(LT)后丙型肝炎病毒(HCV)动力学对于设计预防移植物HCV感染的策略可能很重要。我们分析了20例因HCV相关肝硬化接受LT的连续患者在LT期间及术后即刻的HCV动力学。在移植前、移植期间和移植后定期采集的血样中对HCV RNA进行定量。20例患者中有18例在无肝期HCV RNA浓度下降(平均衰减斜率-0.92,平均HCV清除半衰期2.2小时)。我们发现无肝期HCV病毒载量衰减与失血之间存在显著相关性,这表明观察到的HCV清除率是最大估计值。事实上,1例无肝期异常长(20小时)且失血最少的患者,其HCV清除半衰期为10.3小时。移植肝再灌注后8至24小时,19例患者的HCV病毒载量急剧下降(平均衰减斜率-0.34,平均HCV清除半衰期3.44小时)。仅1例患者的HCV RNA变得不可检测。在接下来的几天里,10例患者的HCV-RNA浓度迅速升高(平均HCV倍增时间13.8小时),4例患者保持在相似水平,6例患者继续下降。与第二阶段病毒载量衰减相关的唯一变量是免疫抑制方案中未使用皮质类固醇。总之,在无肝期及移植肝再灌注后即刻,HCV病毒载量急剧下降,最可能是由于病毒粒子产生缺乏和肝脏病毒清除。然而,移植物的HCV感染是一个极其动态的过程,病毒复制在LT后数小时开始。